Ocenes RR, Alsina VJ, Fernández PM, Luna AMC

Language: Spanish
References: 17
Page: 174-179
PDF size: 101.17 Kb.

ABSTRACT

Introduction and objectives: Cardiovascular diseases are the fourth leading cause of death during the gravid-puerperal period, and an indicator of morbidity and mortality for the product of conception. The objective of this research was to determine the behavior of heart disease in pregnant women, its medical care and evolution during and after pregnancy. Method: A prospective descriptive study was performed, which analyzed 283 pregnant women diagnosed with heart disease, and treated at the Obstetrics and Gynecology University Hospital "Mariana Grajales" in Santa Clara, Villa Clara, in the period 2008-2010. Information was obtained through review of individual medical records, interview, complete physical examination and laboratory tests to establish or confirm the diagnosis. Results: A heart disease incidence of 17.2 per thousand pregnant women was obtained and in 59.7% of them, the heart disease was acquired, and the mitral valve prolapse was the most frequent (45%). Of the congenital diseases, 36.8% was an atrial septal defect. Antibiotic prophylaxis was used in 96.8% of pregnant women and in 96.1% of them a medical monitoring was kept. 92.6% had functional class I and 4.6% presented disease-related complications. 77.4% gave birth between 37 and 42 weeks, and 82.7% had vaginal delivery. Conclusions: Pregnant women with heart disease were more common in ages 20 to 29 years, predominantly in those who had not given birth, whose pregnancies had been detected between 13 and 24 weeks, and with acquired heart diseases. The prevailing medical care was antibiotic prophylaxis and medical monitoring with satisfactory final outcome of pregnancy.

REFERENCES

1. Botella Llusiá J, Clavero Núñez JA. Enfermedades que complican la gestación. En: Tratado de Gine-cología. La Habana: Científico Técnica; 1984. p. 111-28.

2. Rodríguez Hidalgo N, Cuité León E, Cordero Isaac R. Cardiopatías y embarazo. En: Manual de diag-nóstico y tratamiento en Obstetricia y Perinatología. La Habana: Ecimed; 2000. p. 294-304.

3. Beischer NA, Mc Kay EV, Colditz P. Trastornos cardíacos. En: Obstetricia y Neonatología. 3ra ed. México: Mc Graw Hill Interamericana; 2000. p. 369-72.

4. Salazar E. Embarazo en pacientes con cardiopatía reumática. Arch Cardiol Mex. 2001;71(1):S160-3.

5. Schlemmer M. Pregnancy in patient with congenital heart defect. Wien Klin. Wochenschr. 1995;107(20): 608-12.

6. Elkayan V. Embarazo y enfermedad cardiovascular. En: Braunwald E. Braunwald Tratado de Cardiolo-gía. 5ta ed. México: Mc Graw Hill Interamericana; 1999. p. 2021-43.

7. Szelerky P, Turner R, Snaith L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J. 1973;35(12):1293-303.

8. Friedman WF, Silverman N. Cardiopatía congénita en la lactancia y en la infancia. En: Braunwalds E, Zipes DP, Lobby P. Braunwald Cardiología: “El libro” de medicina cardiovascular. 6ta ed. España: MARBÁN; 2004. p. 1839-1943.

9. Schlant RC. Congenital heart disease. En: Stein JH, Eisemberg JM, Hutton JJ, Klippel JH, Kohler PO, La Russo NF. Internal Medicine. 15ta ed. St. Louis: Mosby; 2002. p. 280-91.

10. Zuber M, Gautschi N, Dechslim E, Widmer V, Klaunski W, Jenni R. Autcome of pregnancy in women with congenital shurt lesions. Heart. 1999; 81(3):271-5.

11. Prebistero P, Somerville J, Stones S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy cyanotic congenital heart disease. Outcase of mother and fetus. Circulation. 1994;89(6):165.

12. Dajani AS, Taubert K A, Wilson W, Bolger AF, Ba-yer A, Ferrieri P, et al. Prevention of bacterial endo-carditis. Recomendation by the American Heart Association. Clin Infect Dis. 1997;25(6):1448-58.

13. Aguilera C, Agusti A. Anticoagulación en mujeres embarazadas con prótesis valvular cardíaca mecá-nica. Med Clin (Barc). 2003;121(19):755-6.

14. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anti-coagulation at pregnant woman with mechanical hearth valves. Arch Intern Med. 2003;163;(6):694-8.

15. Pérez Ramírez M, Estévez Muguencia R, Abad Lo-yola PL, Pérez Ramírez R. Comportamiento de las enfermedades cardiovasculares asociadas al emba-razo. Rev Cubana Obstet Ginecol [Internet]. 1999 [citado 8 Mayo 2011];25(1):[aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X1999000100008&lng=es.

16. Salazar E, Espinola N, Román L, Casanova JM. Affect of pregnancy on the during of bovine peri-cardial bioprother. Am Hearth J. 1999;137(4 Pt 1): 714-20.

17. Wada H, Chiba Y, Murakami M, Kawaquchi H, Kan-zaki T. Analis of maternal and fetal risk in 594 preg-nancies with heart disease. 1996;48(4):255-62.